Quantcast

Latest HPV vaccine Stories

2014-09-22 08:28:19

Expansion Comes After Successful Phase II Trial for Cervical Dysplasia PLYMOUTH MEETING, Pa., Sept. 22, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today it has initiated a phase I clinical trial in patients with aerodigestive cancers. The trial will evaluate the safety, tolerability, and immunogenicity of INO-3106. This immunotherapy targets human papillomavirus type 6 (HPV-6), which causes most aerodigestive cancers. Aerodigestive cancers affect the...

2014-09-10 23:01:22

"Vaccines save lives. We now can protect our youth from diseases including cancer — who doesn't want that protection for his or her child?” declares Amy Middleman, MD, MPH, MSEd, FSAHM, adolescent health expert featured in PBS special. Deerfield, IL (PRWEB) September 10, 2014 Vaccines aren’t just for infants; teens and young adults benefit greatly from a number of vaccines that prevent various cancers and other illnesses. This is the message of a new film from PBS/NOVA,...

2014-09-10 16:23:00

ATLANTA, Sept. 10, 2014 /PRNewswire-USNewswire/ -- Millions of infants, children and adolescents in the United States did not receive key clinical preventive services, according to a report published by the Centers for Disease Control and Prevention (CDC) in today's Morbidity and Mortality Weekly Report (MMWR) Supplement. Clinical preventive services are various forms of important medical or dental care that support healthy development. They are delivered by doctors, dentists, nurses and...

2014-08-27 08:27:38

KIGALI, Rwanda, Aug. 27, 2014 /PRNewswire-USNewswire/ -- Seraphine Mukandutiye, 50, is a Rwandan woman with a beautiful and glowing smile. But beneath her soft heart and warm smile, lies a deadly monster waiting to strike. She is battling a cervical cancer. The preventable cancer results from a genital infection caused by a Human Papilloma Virus (HPV). Hundreds of Rwandan women are suffering from the silent killer, others have died. The cancer is one of the major killers among...

2014-08-25 08:27:55

SEATTLE, Aug. 25, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that results from two independent clinical studies were presented at the 29th International Papillomavirus (IPV) Conference. Results from both pilot studies consistently demonstrated that the Company's urine-based assay for the detection of high-risk HPV had high sensitivity (greater than 90%) for identifying women with high grade cervical...

2014-08-22 12:25:19

LA JOLLA, Cali., Aug. 22, 2014 /PRNewswire/ -- Research presented at the 29(th) Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervical cancer. When tested in several cultured human cell models, HTI-1968 blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to Louise T. Chow, Ph.D. and Thomas Broker, Ph.D., who...

2014-08-21 23:15:41

Lesscancer.org Board member Margaret I. Cuomo, M. D. is a member of New York State Comprehensive Cancer Control Plan. (PRWEB) August 21, 2014 Next Generation Choices Foundation, more widely known as Lesscancer.org, is pleased to announce the launch of the New York State Comprehensive Cancer Control Plan Dashboard (the Dashboard) in partnership with the New York State Cancer Consortium (the Consortium). The Consortium is a network of individuals and organizations that collaborate to...

2014-08-01 10:49:36

Landes Bioscience A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than nine years, and vaccine efficacy (VE) against incident infection was 100%. This is the longest follow-up report for a licensed HPV vaccine. Visit https://www.landesbioscience.com/journals/vaccines/article/29532/...

2014-07-23 08:32:38

Treatment with VGX-3100 induces regression of precancerous cervical disease and clears HPV infection with robust T cell responses PLYMOUTH MEETING, Pa., July 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated with human papillomavirus (HPV) types 16 or 18. Treatment...

2014-06-23 04:20:45

Inovio's Immunotherapy will Treat Women with Inoperable HPV-caused Cancer BLUE BELL, Pa., June 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity, clinical responses and disease-free survival of its DNA immunotherapy product, INO-3112, in treating human papillomavirus (HPV)-associated cervical cancer. INO-3112 is a combination of Inovio's lead active immunotherapy...


Latest HPV vaccine Reference Libraries

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related